Literature DB >> 1322573

The interaction of L-triiodothyronine and 2,3,7,8-tetrachlorodibenzo-p-dioxin on Ah-receptor-mediated hepatic Phase I and Phase II enzymes and iodothyronine 5'-deiodinase in thyroidectomized rats.

S E Eltom1, J G Babish, D C Ferguson.   

Abstract

Across all levels of L-triiodothyronine (L-T3) treatment, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) resulted in increased hepatic cytochrome P-450-associated activities of 7-ethoxycoumarin O-deethylase (ECOD), 7-ethoxyresorufin O-dealkylase (EROD) and aryl hydrocarbon hydroxylase (AHH). The treatment of thyroidectomized rats with L-T3 at physiologic replacement levels in concert with TCDD produced an increase in ECOD, EROD and AHH activity above that seen with only TCDD. TCDD as well as L-T3 enhanced the activity of hepatic 1-naphthol glucuronyl transferase (NGT). In addition, the combined effect of L-T3 and TCDD resulted in similar levels of induction of NGT at both physiologic and supraphysiologic doses of L-T3. TCDD treatment resulted in elevated serum T3 levels at both physiologic and supraphysiologic levels of L-T3. One TCDD dose inhibited hepatic microsomal 3,3',5'-triiodothyronine (reverse T3) 5'-deiodinase activity by 61% in thyroidectomized, T3-untreated rats. The inhibition of 5'-deiodinase activity was partially overcome by increasing the T3 dose.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1322573     DOI: 10.1016/0378-4274(92)90139-b

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  2 in total

1.  Effects of developmental exposure to polychlorinated biphenyls and/or polybrominated diphenyl ethers on cochlear function.

Authors:  Emily Poon; Brian E Powers; Ruth M McAlonan; Duncan C Ferguson; Susan L Schantz
Journal:  Toxicol Sci       Date:  2011-08-26       Impact factor: 4.849

2.  Halogen Bonding Interactions of Polychlorinated Biphenyls and the Potential for Thyroid Disruption.

Authors:  Eric S Marsan; Craig A Bayse
Journal:  Chemistry       Date:  2020-02-25       Impact factor: 5.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.